Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Front Immunol ; 12: 754208, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34733286

RESUMEN

The autonomic nervous system has been studied for its involvement in the control of macrophages; however, the mechanisms underlying the interaction between the adrenergic receptors and alternatively activated macrophages (M2) remain obscure. Using FVB wild-type and beta 2 adrenergic receptors knockout, we found that ß2-AR deficiency alleviates hepatobiliary damage in mice infected with C. sinensis. Moreover, ß2-AR-deficient mice decrease the activation and infiltration of M2 macrophages and decrease the production of type 2 cytokines, which are associated with a significant decrease in liver fibrosis in infected mice. Our in vitro results on bone marrow-derived macrophages revealed that macrophages from Adrb2-/- mice significantly decrease M2 markers and the phosphorylation of ERK/mTORC1 induced by IL-4 compared to that observed in M2 macrophages from Adrb2+/+ . This study provides a better understanding of the mechanisms by which the ß2-AR enhances type 2 immune response through the ERK/mTORC1 signaling pathway in macrophages and their role in liver fibrosis.


Asunto(s)
Clonorquiasis/complicaciones , Cirrosis Hepática Biliar/inmunología , Cirrosis Hepática/inmunología , Activación de Macrófagos , Neuroinmunomodulación/fisiología , Receptores Adrenérgicos beta 2/fisiología , Animales , Sistema Nervioso Autónomo/fisiopatología , Conductos Biliares/parasitología , Conductos Biliares/patología , Células Cultivadas , Clonorquiasis/inmunología , Clonorquiasis/fisiopatología , Citocinas/sangre , Humanos , Cirrosis Hepática/etiología , Cirrosis Hepática/parasitología , Cirrosis Hepática/patología , Cirrosis Hepática Biliar/etiología , Cirrosis Hepática Biliar/parasitología , Cirrosis Hepática Biliar/patología , Sistema de Señalización de MAP Quinasas , Macrófagos/clasificación , Macrófagos/inmunología , Masculino , Diana Mecanicista del Complejo 1 de la Rapamicina/fisiología , Ratones Noqueados , Receptores Adrenérgicos beta 2/deficiencia , Organismos Libres de Patógenos Específicos
2.
World J Gastroenterol ; 27(48): 8201-8215, 2021 Dec 28.
Artículo en Inglés | MEDLINE | ID: mdl-35068865

RESUMEN

S-palmitoylation is one of the most common post-translational modifications in nature; however, its importance has been overlooked for decades. Crohn's disease (CD), a subtype of inflammatory bowel disease (IBD), is an autoimmune disease characterized by chronic inflammation involving the entire gastrointestinal tract. Bowel damage and subsequent disabilities caused by CD are a growing global health issue. Well-acknowledged risk factors for CD include genetic susceptibility, environmental factors, such as a westernized lifestyle, and altered gut microbiota. However, the pathophysiological mechanisms of this disorder are not yet comprehensively understood. With the rapidly increasing global prevalence of CD and the evident role of S-palmitoylation in CD, as recently reported, there is a need to investigate the relationship between CD and S-palmitoylation. In this review, we summarize the concept, detection, and function of S-palmitoylation as well as its potential effects on CD, and provide novel insights into the pathogenesis and treatment of CD.


Asunto(s)
Enfermedad de Crohn , Microbioma Gastrointestinal , Enfermedades Inflamatorias del Intestino , Enfermedad de Crohn/diagnóstico , Enfermedad de Crohn/epidemiología , Enfermedad de Crohn/genética , Humanos , Lipoilación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...